Novo Nordisk says Wegovy approved in China for MASH
Novo Nordisk said Wegovy has been approved in China as the first and only GLP-1 RA for the treatment of MASH.
Novo Nordisk OMXCOP:NOVO_B said on Thursday that Wegovy has been approved in China as the first and only GLP-1 RA for the treatment of MASH.